
亚太地区主患者指数软件市场预测至 2028 年 - COVID-19 影响和按类型(软件和服务)进行区域分析;部署(基于云和本地)
No. of Pages: 93 | Report Code: TIPRE00023499 | Category: Technology, Media and Telecommunications
No. of Pages: 93 | Report Code: TIPRE00023499 | Category: Technology, Media and Telecommunications
主患者指数(MPI)是每家医院或医疗机构中心的重要组成部分。维护庞大的患者数据库使用 MPI 软件或系统。 MPI 软件或系统是电子健康记录 (HER) 中构建的主要功能,用于在组织级别维护患者的通用身份。 MPI 有助于连接多个数据库中的患者记录并减少患者的数据重复。 MPI 还有助于避免因数据不准确而导致治疗不当。
因此,基于云的技术的采用预计将在未来几年对主患者索引软件产生巨大需求,进一步预计将推动主患者索引软件市场。
COVID-19 大流行给世界许多国家的卫生系统带来了重大压力。在大流行初期,许多亚太国家的检测能力有限且质量低下,导致 COVID-19 病例激增。然而,韩国、日本和新加坡等许多国家通过强有力的跟踪和测试,有效地控制了局势。此外,印度的病例数位居世界第二,仅次于美国。即使在疫情期间,现有医疗保健系统的负担日益加重,以及对先进数据收集和分析技术的需求不断增长,预计将推动亚太地区主患者指数软件市场的发展。 2021 年 1 月,重要的临床和基因组数据管理公司 BC Platforms 宣布与日本 RIKEN 研究机构和芬兰健康与福利研究所 (‘THL’) 合作。此外,随着医疗保健系统数字化的采用、该地区发展中国家对远程患者护理的日益青睐,以及越来越多的监管机构强调价值和患者结果,患者参与预计将增加远程患者护理的采用。未来几年掌握患者索引软件。
亚太地区的主患者索引软件市场预计将从 2021 年的 1.803 亿美元增长到到 2028 年将达到 3.712 亿美元;预计 2021 年至 2028 年复合年增长率为 10.9%。向无纸化数据管理的重大转变使各种医疗保健参与者能够采用基于云的技术。此外,基于云的技术成本的降低、灵活性和安全性的提高以及低维护要求和成本都进一步推动了医疗机构对这些技术的采用。这些优势有助于为患者提供高质量的服务和个人护理。基于云的技术消除了互操作性问题,同时实现了与医疗保健组织的轻松数据集成。由于大量可用的医疗数据被组织并保存在云服务器上,因此处理这些数据对于医疗保健专业人员来说变得可行。基于云的技术使医疗保健专业人员能够与不同部门、机构、医疗保健服务提供商和消费者协同运作。此外,技术进步正在支持人工智能(AI)和机器学习在患者管理中的集成,从而帮助用户管理医疗保健运营和海量数据。因此,基于云的技术的采用增加了对主患者索引软件的需求,以简化患者数据管理流程。
从类型来看,软件细分市场在2020年亚太主患者指数软件市场中占据最大份额。从部署来看,云- 2020 年,基于细分市场的主患者索引软件市场占据了更大的市场份额。
准备本亚太地区主患者索引软件市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 McKESSON CORPORATION、Oracle Corporation、Wipro Limited、Allscripts Healthcare Solutions, Inc.、MEDITECH 和 Intersystems Corporation。
按类型
通过部署
按国家/地区
Strategic insights for Asia Pacific Master Patient Index Software involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 180.3 Million |
Market Size by 2028 | US$ 371.2 Million |
Global CAGR (2021 - 2028) | 10.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Master Patient Index Software refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Master Patient Index Software Market is valued at US$ 180.3 Million in 2021, it is projected to reach US$ 371.2 Million by 2028.
As per our report Asia Pacific Master Patient Index Software Market, the market size is valued at US$ 180.3 Million in 2021, projecting it to reach US$ 371.2 Million by 2028. This translates to a CAGR of approximately 10.9% during the forecast period.
The Asia Pacific Master Patient Index Software Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Master Patient Index Software Market report:
The Asia Pacific Master Patient Index Software Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Master Patient Index Software Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Master Patient Index Software Market value chain can benefit from the information contained in a comprehensive market report.